Department of Health
and Human Services (HHS)
and Human Services (HHS)
August 21, 2020
RFA-OD-20-023 - Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)
National Center for Advancing Translational Sciences (NCATS)
The purpose of this Notice is to inform potential applicants of NCATS's participation, effective immediately, in RFA-OD-20-023, "Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)".
The following changes and updates are made to RFA-OD-20-023 (shown in italics) to reflect NCATS’ participation in this funding opportunity announcement (FOA).
Part 1. Overview Information
Components of Participating Organizations
Office of The Director, National Institutes of Health (OD)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute on Minority Health and Health Disparities (NIMHD)
Fogarty International Center (FIC)
National Center for Advancing Translational Sciences (NCATS)
The FOA will be administered by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) on behalf of the NIH.
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.310, 93.865, 93.989, 93.837, 93.838, 93.839, 93.840, 93.233, 93.855, 93.846, 93.279, 93.307, 93.350
Joan Nagel, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-2512
Email: [email protected]